Header Logo

Connection

Parameswaran Venugopal to Naphthalimides

Back to Details
This is a "connection" page, showing publications Parameswaran Venugopal has written about Naphthalimides.
Parameswaran Venugopal
Connection Strength
0.032
Naphthalimides
  1. Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia. J Clin Oncol. 2015 Apr 10; 33(11):1252-7.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.